VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
-9.87%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$16.1B
AUM Growth
-$2.79B
(-15%)
Cap. Flow
-$261M
Cap. Flow
% of AUM
-1.62%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
844
New
146
Increased
323
Reduced
295
Closed
69
Top Buys
| 1 |
Kinder Morgan
KMI
|
$117M |
| 2 |
Valero Energy
VLO
|
$113M |
| 3 |
IAMGOLD
IAG
|
$94.3M |
| 4 |
Hecla Mining
HL
|
$87.9M |
| 5 |
CF Industries
CF
|
$66.5M |
Top Sells
| 1 |
GG
Goldcorp Inc
GG
|
$199M |
| 2 |
B
Barrick Mining Corporation
B
|
$164M |
| 3 |
ANDV
Andeavor
ANDV
|
$125M |
| 4 |
Newmont
NEM
|
$122M |
| 5 |
Franco-Nevada
FNV
|
$105M |
Sector Composition
| 1 | Materials | 44.02% |
| 2 | Energy | 24.21% |
| 3 | Healthcare | 6.87% |
| 4 | Industrials | 3.71% |
| 5 | Technology | 3.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MHG
151
DELISTED
Marine Harvest ASA
MHG
| $16.8M | 0.1% |
+1,231,859
| New | +$16.8M |
|
|
PCYC
152
DELISTED
PHARMACYCLICS INC
PCYC
| $16.8M | 0.1% |
137,457
-20,535
| -13% | -$2.51M |
|
|
DO
153
DELISTED
Diamond Offshore Drilling
DO
| $16.7M | 0.1% |
455,880
+57,504
| +14% | +$2.11M |
|
154
Idexx Laboratories
IDXX
$51.4B
| $16.5M | 0.1% |
222,644
-40,242
| -15% | -$2.98M |
|
|
SVM
155
Silvercorp Metals
SVM
$1.08B
| $16.4M | 0.1% |
12,625,712
-12,490,590
| -50% | -$16.2M |
|
156
Broadcom
AVGO
$1.58T
| $16.4M | 0.1% |
1,627,680
-188,050
| -10% | -$1.89M |
|
|
EXK
157
Endeavour Silver
EXK
$1.74B
| $16.3M | 0.1% |
7,534,541
-7,913,228
| -51% | -$17.1M |
|
158
Sanofi
SNY
$113B
| $16.3M | 0.1% |
356,814
-46,403
| -12% | -$2.12M |
|
159
NXP Semiconductors
NXPI
$57.2B
| $16.1M | 0.1% |
+211,228
| New | +$16.1M |
|
160
GSK
GSK
$81.5B
| $16.1M | 0.1% |
301,008
-38,521
| -11% | -$2.06M |
|
161
AbbVie
ABBV
$375B
| $15.8M | 0.1% |
242,138
-73,642
| -23% | -$4.82M |
|
162
Analog Devices
ADI
$122B
| $15.7M | 0.1% |
282,433
-32,474
| -10% | -$1.8M |
|
163
Merck
MRK
$212B
| $15.5M | 0.1% |
285,911
-129,081
| -31% | -$6.99M |
|
164
Ionis Pharmaceuticals
IONS
$9.76B
| $15.2M | 0.09% |
246,868
+29,062
| +13% | +$1.79M |
|
165
Novo Nordisk
NVO
$245B
| $15.1M | 0.09% |
714,878
-158,508
| -18% | -$3.35M |
|
166
McEwen Inc.
MUX
$734M
| $15.1M | 0.09% |
1,362,326
-2,774,524
| -67% | -$30.8M |
|
|
AGN
167
DELISTED
ALLERGAN INC
AGN
| $15M | 0.09% |
70,561
-20,477
| -22% | -$4.35M |
|
168
Abbott
ABT
$231B
| $14.9M | 0.09% |
331,917
-89,051
| -21% | -$4.01M |
|
169
Bristol-Myers Squibb
BMY
$96B
| $14.7M | 0.09% |
248,435
-105,116
| -30% | -$6.2M |
|
170
Home Depot
HD
$417B
| $14.6M | 0.09% |
139,125
+81,270
| +140% | +$8.53M |
|
|
WLB
171
DELISTED
Westmoreland Coal Company
WLB
| $14.6M | 0.09% |
439,700
-13,700
| -3% | -$455K |
|
|
RDC
172
DELISTED
Rowan Companies Plc
RDC
| $14.6M | 0.09% |
625,534
+51,030
| +9% | +$1.19M |
|
173
Eli Lilly
LLY
$652B
| $14.4M | 0.09% |
208,895
-60,963
| -23% | -$4.21M |
|
174
AstraZeneca
AZN
$253B
| $14.1M | 0.09% |
400,032
-83,494
| -17% | -$2.94M |
|
|
CVD
175
DELISTED
COVANCE INC.
CVD
| $13.7M | 0.09% |
131,647
+12,984
| +11% | +$1.35M |
|